Literature DB >> 8700864

A targeted mutation of the D3 dopamine receptor gene is associated with hyperactivity in mice.

D Accili1, C S Fishburn, J Drago, H Steiner, J E Lachowicz, B H Park, E B Gauda, E J Lee, M H Cool, D R Sibley, C R Gerfen, H Westphal, S Fuchs.   

Abstract

While most effects of dopamine in the brain are mediated by the D1 and D2 receptor subtypes, other members of this G protein-coupled receptor family have potentially important functions. D3 receptors belong to the D2-like subclass of dopamine receptors, activation of which inhibits adenylyl cyclase. Using targeted mutagenesis in mouse embryonic stem cells, we have generated mice lacking functional D3 receptors. A premature chain-termination mutation was introduced in the D3 receptor gene after residue Arg-148 in the second intracellular loop of the predicted protein sequence. Binding of the dopamine antagonist [125I]iodosulpride to D3 receptors was absent in mice homozygous for the mutation and greatly reduced in heterozygous mice. Behavioral analysis of mutant mice showed that this mutation is associated with hyperactivity in an exploratory test. Homozygous mice lacking D3 receptors display increased locomotor activity and rearing behavior. Mice heterozygous for the D3 receptor mutation show similar, albeit less pronounced, behavioral alterations. Our findings indicate that D3 receptors play an inhibitory role in the control of certain behaviors.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8700864      PMCID: PMC39888          DOI: 10.1073/pnas.93.5.1945

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  29 in total

1.  Topographic nonoverlapping distribution of D1 and D2 dopamine receptors in the amygdaloid nuclear complex of the rat brain.

Authors:  R J Scibilia; J E Lachowicz; C D Kilts
Journal:  Synapse       Date:  1992-06       Impact factor: 2.562

Review 2.  Doyne Lecture. Rhodopsin and autosomal dominant retinitis pigmentosa.

Authors:  T P Dryja
Journal:  Eye (Lond)       Date:  1992       Impact factor: 3.775

Review 3.  Molecular biology of dopamine receptors.

Authors:  D R Sibley; F J Monsma
Journal:  Trends Pharmacol Sci       Date:  1992-02       Impact factor: 14.819

4.  Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics.

Authors:  P Sokoloff; B Giros; M P Martres; M L Bouthenet; J C Schwartz
Journal:  Nature       Date:  1990-09-13       Impact factor: 49.962

5.  A novel short isoform of the D3 dopamine receptor generated by alternative splicing in the third cytoplasmic loop.

Authors:  C S Fishburn; D Belleli; C David; S Carmon; S Fuchs
Journal:  J Biol Chem       Date:  1993-03-15       Impact factor: 5.157

Review 6.  Recent advances in the molecular biology of dopamine receptors.

Authors:  J A Gingrich; M G Caron
Journal:  Annu Rev Neurosci       Date:  1993       Impact factor: 12.449

7.  Early neonatal death in mice homozygous for a null allele of the insulin receptor gene.

Authors:  D Accili; J Drago; E J Lee; M D Johnson; M H Cool; P Salvatore; L D Asico; P A José; S I Taylor; H Westphal
Journal:  Nat Genet       Date:  1996-01       Impact factor: 38.330

8.  Dopamine D3 receptor mRNA and binding sites in human brain.

Authors:  B Landwehrmeyer; G Mengod; J M Palacios
Journal:  Brain Res Mol Brain Res       Date:  1993-04

9.  Pharmacology of human dopamine D3 receptor expressed in a mammalian cell line: comparison with D2 receptor.

Authors:  P Sokoloff; M Andrieux; R Besançon; C Pilon; M P Martres; B Giros; J C Schwartz
Journal:  Eur J Pharmacol       Date:  1992-04-10       Impact factor: 4.432

10.  Localization of dopamine D3 receptor mRNA in the rat brain using in situ hybridization histochemistry: comparison with dopamine D2 receptor mRNA.

Authors:  M L Bouthenet; E Souil; M P Martres; P Sokoloff; B Giros; J C Schwartz
Journal:  Brain Res       Date:  1991-11-15       Impact factor: 3.252

View more
  103 in total

1.  Activation of human D3 dopamine receptor inhibits P/Q-type calcium channels and secretory activity in AtT-20 cells.

Authors:  E V Kuzhikandathil; G S Oxford
Journal:  J Neurosci       Date:  1999-03-01       Impact factor: 6.167

2.  Behavioral actions of alcohol: phenotypic relations from multivariate analysis of mutant mouse data.

Authors:  Y A Blednov; R D Mayfield; J Belknap; R A Harris
Journal:  Genes Brain Behav       Date:  2012-04-06       Impact factor: 3.449

3.  Essential conservation of D1 mutant phenotype at the level of individual topographies of behaviour in mice lacking both D1 and D3 dopamine receptors.

Authors:  John Y F Wong; Jeremiah J Clifford; Jim S Massalas; Anthony Kinsella; John L Waddington; John Drago
Journal:  Psychopharmacology (Berl)       Date:  2003-03-22       Impact factor: 4.530

4.  Alterations in postnatal neurogenesis and dopamine dysregulation in schizophrenia: a hypothesis.

Authors:  Dragos Inta; Andreas Meyer-Lindenberg; Peter Gass
Journal:  Schizophr Bull       Date:  2010-11-19       Impact factor: 9.306

Review 5.  Pharmacogenetics and antipsychotics: therapeutic efficacy and side effects prediction.

Authors:  Jian-Ping Zhang; Anil K Malhotra
Journal:  Expert Opin Drug Metab Toxicol       Date:  2011-01       Impact factor: 4.481

6.  β-arrestin2 plays permissive roles in the inhibitory activities of RGS9-2 on G protein-coupled receptors by maintaining RGS9-2 in the open conformation.

Authors:  Mei Zheng; Sang-Yoon Cheong; Chengchun Min; Mingli Jin; Dong-Im Cho; Kyeong-Man Kim
Journal:  Mol Cell Biol       Date:  2011-10-17       Impact factor: 4.272

7.  Absence of amino acid-induced glomerular hyperfiltration in dopamine D3 receptor knockout mice.

Authors:  Gerd Luippold; Bärbel Pech; Swetlana Schneider; Karla Drescher; Reinhold Müller; Gerhard Gross; Bernd Mühlbauer
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2005-12-22       Impact factor: 3.000

Review 8.  Phenotypic studies on dopamine receptor subtype and associated signal transduction mutants: insights and challenges from 10 years at the psychopharmacology-molecular biology interface.

Authors:  John L Waddington; Colm O'Tuathaigh; Gerard O'Sullivan; Katsunori Tomiyama; Noriaki Koshikawa; David T Croke
Journal:  Psychopharmacology (Berl)       Date:  2005-09-29       Impact factor: 4.530

9.  Genetic susceptibility to Parkinson's disease among South and North Indians: I. Role of polymorphisms in dopamine receptor and transporter genes and association of DRD4 120-bp duplication marker.

Authors:  Ramesh C Juyal; Mitashree Das; Sohan Punia; Madhuri Behari; Geetika Nainwal; Sumit Singh; Pazhayannur V Swaminath; Shyla T Govindappa; Sachi Jayaram; Uday B Muthane; B K Thelma
Journal:  Neurogenetics       Date:  2006-07-01       Impact factor: 2.660

Review 10.  Modeling the positive symptoms of schizophrenia in genetically modified mice: pharmacology and methodology aspects.

Authors:  Maarten van den Buuse
Journal:  Schizophr Bull       Date:  2009-11-09       Impact factor: 9.306

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.